Taiwan Positions Itself as Cell and Therapy Hub

Health authorities have highlighted Taiwan's world-class clinical trial infrastructure and regulatory reforms to scale up advanced cell and gene therapy developments, aiming to capture leadership across Asia.

HPC Consultancy assists healthcare providers, biotech innovators, and medical tourism operators in expanding international market reach, regulatory compliance, and cross-border clinical collaborations.